Clinical Trial Update: Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism [NA]

View source ↗

Summary

Clinical trial evaluating the effect of Androgel on atherogenesis in men with type 2 diabetes and hypogonadotrophic hypogonadism; study terminated with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherogenesis
• Hypogonadotropic Hypogonadism
• Type 2 Diabetes Mellitus

Drugs mentioned

• ANDROGEL (Testosterone)

Snippet

Sponsor: University at Buffalo | Conditions: Type 2 Diabetic Male With Hypogonadotrophic Hypogonadism | NA | Status: TERMINATED | Results posted: 2024-02-06